mifepristone has been researched along with stilbenes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, JH; Chang, C; Flatt, T; Helfand, SL; Morris, SN; Wood, JG | 1 |
| Chen, L; Fuchs, PM; Kanazirska, MV; Lal, S; Vassilev, PM; Verma, J | 1 |
2 other study(ies) available for mifepristone and stilbenes
| Article | Year |
|---|---|
dSir2 and Dmp53 interact to mediate aspects of CR-dependent lifespan extension in D. melanogaster.
Topics: Age Factors; Animals; Animals, Genetically Modified; Biocatalysis; Caloric Restriction; DNA; Drosophila melanogaster; Drosophila Proteins; Female; Gene Expression; Histone Deacetylases; Immunoprecipitation; Kinetics; Longevity; Mifepristone; Peptide Fragments; Protein Binding; Protein Interaction Mapping; Recombinant Proteins; Resveratrol; Signal Transduction; Sirtuins; Stilbenes; Survival Analysis; Transfection; Tumor Suppressor Protein p53 | 2009 |
Beneficial effects of lysosome-modulating and other pharmacological and nanocarrier agents on amyloid-beta-treated cells.
Topics: Acetylcarnitine; Alzheimer Disease; Amyloid beta-Peptides; Cell Line, Tumor; Cell Survival; Drug Carriers; Endosomes; Humans; Kaempferols; Lactic Acid; Lysosomes; Memantine; Mifepristone; Nanoparticles; Neuroprotective Agents; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Resveratrol; Stilbenes | 2012 |